An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease
Clinical trial NCT03770299 · WITHDRAWN
Trial details
- NCT number
- NCT03770299
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-15
- Primary completion
- 2023-03-14
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.